MAP2K3 promotes apoptosis and inhibits cell growth in ESCC cells and functionally exerts its effects through the downregulation of the EGFR/STAT3 pathway by promoting STAT3 proteasome degradation. The gene discussed is EGFR; the disease is esophageal squamous cell carcinoma.